Differential Recruitment of Pre-mRNA Splicing Factors to Alternatively Spliced Transcripts In Vivo by Mabon, Stephen A & Misteli, Tom
Differential Recruitment of Pre-mRNA
Splicing Factors to Alternatively Spliced
Transcripts In Vivo
Stephen A. Mabon, Tom Misteli
*
National Cancer Institute, National Institutes of Health, Bethesda, Maryland, United States of America
Alternative splicing in mammalian cells has been suggested to be largely controlled by combinatorial binding of basal
splicing factors to pre-mRNA templates. This model predicts that distinct sets of pre-mRNA splicing factors are
associated with alternatively spliced transcripts. However, no experimental evidence for differential recruitment of
splicing factors to transcripts with distinct splicing fates is available. Here we have used quantitative single-cell
imaging to test this key prediction in vivo. We show that distinct combinations of splicing factors are recruited to sites
of alternatively spliced transcripts in intact cells. While a subset of serine/arginine protein splicing factors, including
SF2/ASF, SC35, and SRp20, is efficiently recruited to the tau gene when exon 10 is included, these factors are less
frequently associated with tau transcription sites when exon 10 is excluded. In contrast, the frequency of recruitment
of several other splicing factors is independent of splicing outcome. Mutation analysis of SF2/ASF shows that both
protein–protein as well as protein–RNA interactions are required for differential recruitment. The differential behavior
of the various splicing factors provides the basis for combinatorial occupancy at pre-mRNAs. These observations
represent the first in vivo evidence for differential association of pre-mRNA splicing factors with alternatively spliced
transcripts. They confirm a key prediction of a stochastic model of alternative splicing, in which distinct combinatorial
sets of generic pre-mRNA splicing factors contribute to splicing outcome.
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Introduction
Pre-mRNA splicing is one of the key steps in the
maturation of newly synthesized transcripts. During the
splicing process, non-coding intron sequences are removed
and the coding exon sequences are joined in a multi-step
reaction, carried out by the spliceosome, a large protein
complex consisting of small ribonucleoprotein particles
(snRNP), and associated non-snRNP proteins [1,2]. The major
class of non-snRNPs are the serine-arginine rich SR-proteins,
characterized by the presence of one or two RNA-binding
domains and a C-terminal SR-rich domain (RS-domain)[3,4].
The spliceosome carries out the splicing reaction in a series
of complex spatial and temporal conformational rearrange-
ments leading to the alignment of the reaction substrates and
formation of the spliced mRNA [1,2].
While many introns are constitutively excised during
splicing, other introns are subject to alternative splicing.
During the alternative splicing reaction multiple mRNA
species are generated by combinatorial inclusion or exclusion
of exons [5–9]. Alternative splicing is rapidly emerging as a
ubiquitous cellular event with estimates suggesting that 60%–
90% of human genes are alternatively spliced [10]. Alter-
native splicing thus contributes signiﬁcantly to protein
diversity beyond that encoded in the genome sequence.
Defects in alternative splicing and generation of aberrant
ratios of multiple mRNA isoforms from a single gene are now
also recognized as major contributors to human disease [11–
13]. Amongst many others, alternative splicing defects have
been identiﬁed as the cause of numerous diseases including b-
thalassemia, cystic ﬁbrosis, and premature aging [11].
The molecular basis for how alternative splice sites are
selected is still largely unclear [7]. Although a handful of,
often tissue-speciﬁc, dedicated splice site selection factors
have been identiﬁed [13–16], the predominant model for
splice site choice envisions that selective usage of an exon is
due to the differential association of distinct sets of generic
splicing factors [8,17]. This model is indirectly supported by
the observation that in vivo and in vitro titration of multiple
factors against each other modulates alternative splice site
switching, presumably by antagonistic competition for splice
sites [18–21]. A key prediction from this model is that
alternatively spliced substrates should have different sets of
splicing factors associated with them. Biochemical ap-
proaches to isolate spliceosomes with differential splicing
factor composition have so far been unsuccessful, likely due
to the heterogeneity of in vitro reactions and/or the transient
nature of the association of splicing factors with their
templates [2].
To circumvent these methodological limitations, we ap-
plied quantitative single cell microscopy to ask whether
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Open access, freely available online PLoS BIOLOGYdifferential sets of splicing factors associate with alternatively
spliced transcripts. This approach is based on the fact that
pre-mRNA splicing factors are non-randomly distributed
within the mammalian cell nucleus. The vast majority of pre-
mRNA splicing components are enriched in distinct nuclear
sub-compartments termed speckles or splicing factor com-
partments [22,23]. Despite the local concentration of splicing
factors in these nuclear domains, they are most likely not
active sites of pre-mRNA splicing but represent storage/
assembly sites for splicing components [24–26]. Activation of
genes near splicing factor compartments results in the
physical recruitment of splicing factors from speckles and
their accumulation at sites of active transcription and
splicing [24]. This accumulation can be detected by quanti-
tative ﬂuorescence microscopy and used as an in vivo assay
for recruitment of factors to pre-mRNA [26–28]. The
observed recruitment is dependent on the functional
interaction of splicing factors with the pre-mRNA since
transcripts with no introns or mutant pre-mRNAs that
cannot be spliced do not recruit splicing factors [28]. In
addition, mutant splicing factors do not accumulate efﬁ-
ciently at transcription sites [27]. Using this quantitative in
vivo single cell microscopy assay, we here provide evidence
for differential recruitment of several splicing factors to
alternatively spliced transcripts. Our ﬁndings conﬁrm a key
prediction of a stochastic, combinatorial recruitment model
for alternative splicing.
Results
An In Vivo Assay for Recruitment of Splicing Factors to
Alternatively Spliced Transcripts
We sought to establish an experimental system to study the
recruitment of splicing factors to alternatively spliced tran-
scripts in vivo. As a model system we used the tau gene, which
encodes a microtubule binding protein and whose aberrant
alternative splicing is the cause of frontotemporal dementia
and parkinsonism linked to chromosome 17 (FTDP-17), a
parkinsonism-like neurological disorder [29]. In healthy
individuals, exon 10 of the tau gene is included or excluded
from the mRNA with roughly equal probability during pre-
mRNA splicing [29]. In contrast, among patients with FTDP-
17 mutations near the 59 splice site of exon 10 result in
predominant inclusion of exon 10 [29–31]. A minigene system
consisting of tau exon 10 ﬂanked by partial tau intron
sequences and HIV TAT exons has previously been used to
mimic the alternative splicing behavior of the full-length
wild-type (wt) and mutant tau gene in COS-7 cells (Figure 1A)
[30,31].
We used this well-characterized minigene to establish an
experimental system to study potential differences in recruit-
ment of splicing factors to alternatively spliced transcripts in
vivo. To this end, monoclonal stable COS-1 cell lines
expressing either tau10wt or tau10 1 were generated (see
Materials and Methods for details). In COS-1 cells stably
expressing tau10wt, exon 10 was predominantly excluded,
whereas in tau10 1 stable cell lines, exon 10 was predom-
inantly included (Figure 1B). This pattern is identical to that
observed for endogenous tau in patients and in the
transiently expressed minigene system [29,30]. Quantitation
by real-time PCR analysis demonstrated a ; 5-fold increase in
exon 10-containing mRNA in tau10 1 cells compared to
Figure 1. Characterization of Stable Cell Lines Expressing Alternatively
Spliced tau Minigenes
(A) Schematic representation of the tau exon 10 minigene system.
Alternative inclusion or exclusion of exon 10 as observed for
endogenous tau is recapitulated in a minigene containing flanking
HIV-TAT exons.
(B) Preferential inclusion of tau exon 10 detected by gel electrophoresis.
The wttau exon 10 (tau10wt) is evenly included or excluded from the
mRNA, whereas a tau exon 10 containing a T.C mutation at position 1
of exon 10 (tau10 1) is predominantly included in the same context. Exon
10 inclusion is detected as a 246-bp by RT-PCR using primers (arrows) in
the TAT exons. Exon 10 exclusion is detected by a 153-bp band.
(C) Quantitative real-time PCR analysis to determine exon 10 inclusion.
Results are averages 6 standard deviations from at least three
experiments.
(D) RNA-FISH using nick-translated probes against the tau minigene to
detect sites of tau transcription. The vast majority of cells in a stable cell
population contained one or two tau minigene insertion sites. Arrow-
heads indicate tau transcription sites. Scale bar ¼ 3.5 lm.
DOI: 10.1371/journal.pbio.0030374.g001
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Recruitment of Splicing Factorstau10wt cells (Figure 1C). The transcription site of the stably
integrated minigene was readily detectable by RNA ﬂuores-
cence in situ hybridization (FISH) using nick-translated
probes to full-length tau mRNA (Figure 1D). Cell clones for
both tau10wt and tau10 1 were isolated containing the
transgene in a single genomic integration site (Figure 1D).
Differential Recruitment of SR-Proteins to Alternatively
Spliced Transcripts
We used this experimental system to ask whether splicing
factors associate differentially with alternatively spliced
transcripts in vivo. To this end we took advantage of a
previously characterized quantitative single cells splicing
factor recruitment assay [27]. In this assay recruitment of a
splicing factor to a speciﬁc transcription site is detected by
simultaneous FISH to visualize the site of transcription and
indirect immunoﬂuorescence (IF) using speciﬁc antibodies to
detect endogenous pre-mRNA splicing factors. As previously
described, positive recruitment of splicing factors is deﬁned
as . 2-fold accumulation of splicing factor signal at the site of
transcription above the global nucleoplasmic signal as
determined by quantitative linescan analysis of single tran-
scription sites (Figure 2A; see Materials and Methods for
details) [27]. The obligatory U2 associated factor U2-B99
served as a positive control and to determine the detection
sensitivity of the recruitment assay. As expected U2-B99 was
detected at sites of transcription with high frequency both in
cells expressing tau exon 10wt or exon 10 1 (Figures 2A and 2
B). Recruitment was detected at the site of tau transcription
in 78 6 6% of exon 10wt cells and 77 6 14% of exon 10 1
cells (Figure 2A and 2B). Somewhat lower accumulations of
typically between 1.3–1.9 fold over the nucleoplasmic signal
were found in most other cells, and no tau transcription sites
were detected that were entirely devoid of U2-B’’ signal
(unpublished data). In contrast to the obligatory splicing
factor U2-B’’, the SR protein SF2/ASF showed differential
recruitment between tau10wt and tau10 1 cells (Figure 2A
and 2B). Endogenous SF2/ASF was recruited to transcription
sites in more than 68 6 6% of tau10 1 cells, but accumulated
at transcription sites in only 31 6 2% of tau10wt cells (Figure
2B). This difference in accumulation was signiﬁcant at the p ,
0.005 level in a Student t-test. The SR protein SC35 behaved
differently from SF2/ASF in that it was only poorly recruited
to either transcript (Figures 2A and 2B). SC35 was recruited
to tau transcription sites in 38 6 13% of tau10wt cells, and to
48 6 2% of sites in tau10 1 cells (Figure 2B). SRp40 in
contrast was recruited to the tau transcript in more than 80%
of cells, regardless of the nature of the transcript (Figure 2B).
Similar observations were made in several clonal cell lines
(unpublished data). The observations that SF2/ASF was
differentially recruited to the two tau transcripts, while
SC35 was recruited to neither and SRp40 was recruited to
both indicate that distinct SR proteins are differentially
recruited to sites of alternatively spliced transcripts in vivo.
To further validate the correlation between recruitment
and exon 10 inclusion, we used a FISH probe complementary
to exon 10, thus speciﬁcally detecting mRNA containing exon
10 (Figure 3). As expected, splicing factors accumulated at
sites of transcription of tau exon 10-containing pre-mRNA
(Figure 3). This probe allowed us to test two predictions of
differential recruitment. If the extent of recruitment indeed
is related to splicing outcome, splicing factors should also be
recruited to the subpopulation of transcription sites in
tau10wt cells, which generate detectable levels of exon 10-
containing tau pre-mRNA. To test this prediction we used the
exon10-speciﬁc FISH probe to visualize tau10wt cells, which
generate detectable levels of exon 10-containing mRNA and
determined whether SF2/ASF and SC35 are recruited to those
sites (Figure 3). As predicted, SF2/ASF and SC35 were
recruited to the subpopulation of transcription sites in wt
cells, at which exon 10-containing RNA could be detected
(Figure 3A). Although fewer than 30% of all transcription
sites in wt cells had splicing factors associated with them
when visualized with a full-length tau probe, more than 90%
of the subpopulation of wt cells in which signiﬁcant levels of
exon 10-containing RNA were detected with the exon 10-
speciﬁc probe recruited SF2/ASF and SC35 (Figure 3B). As
expected, no increase in the percentage of splicing factor
recruitment was found in the tau10 1 cell line when the exon
10-speciﬁc probe was used (Figure 3B). This observation
suggests that the recruitment behavior of splicing factors is
primarily inﬂuenced by the predominant splicing outcome at
a transcription site.
A second prediction from a recruitment model is that the
percentage of cells that generate detectable amounts of
mRNA containing exon 10 should be similar to the
percentage of cells in which recruitment of SF2/ASF and
SC35 is detected when using the full-length probe. Using the
exon 10-speciﬁc FISH probe, we indeed found that the
percentage of cells containing an mRNA-FISH signal for exon
10 was virtually identical to the extent of recruitment
observed using a tau full-length probe. In tau10wt cells, 38
6 8% of cells were positive for exon 10, comparable to the
31 6 2 % and 38 6 13% of cells with recruitment of SF2/ASF
and SC35, respectively. These observations demonstrate that
recruitment of splicing factors is a reﬂection of the
production of exon10-containing RNA at a site of tran-
scription.
Recruitment Is Determined by Splicing Outcome
Tau10wt and the tau10 1 mutant differ in a single residue
at position  1 in the 59 splice site [30]. Although sequence
analysis using manual approaches and EsEFINDER (http://
www. rulai.cshl.org/tools/ESE) did not reveal any strong
consensus binding sites for SF2/ASF or SC35 in this region
(unpublished data), we asked whether the speciﬁc mutation in
 1 was responsible for the differential association of SF2/ASF
or whether differential recruitment of this factor was
correlated with splicing outcome per se. To this end, we
generated stable cell lines expressing tau minigenes contain-
ing a G .A mutation at position þ3( tau10þ3) or a C . U
mutation at position þ14 (tau10þ14). These mutations have
previously been shown to result in preferential inclusion of
exon 10, similar to tau10 1 in patient cells and in transient
transfection assays [30]. As expected, stable cell lines
expressing either tau10þ3 or tau10þ14 preferentially in-
cluded exon 10 (Figure 4A). Quantitative real-time PCR
analysis indicated that inclusion in these cell lines was 3- to 4-
fold above that observed in tau10wt cells (Figure 4B). Similar
to tau10wt and tau10 1 cell lines, typically a single
integration site was detected in these cells by RNA-FISH
(unpublished data). As observed for tau10 1, U2-B’’ and
SRp40 showed no differential recruitment and these proteins
were equally efﬁciently recruited to tau10wt as to tau10þ3o r
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Recruitment of Splicing FactorsFigure 2. Differential Recruitment of Endogenous Pre-RNA Splicing Factors to Alternatively Spliced Transcripts
(A) Recruitment of splicing factors to tau transcription sites detected by combined RNA-FISH using specific probes against the tau minigene (green) and
IF microscopy with specific anti-splicing factor antibodies (red). Arrowheads indicate tau transcription sites. All associations were confirmed by linescan
analysis. Scale bar ¼ 2.5 lm. (Inset: higher magnifications of the transcription site) Lines indicate the location of the linescans.
(B) Quantitation of percentage of cells with colocalization of tau RNA-FISH and splicing factor signals. Values represent averages from at least 100
transcription sites from at least three experiments 6 SEM.
DOI: 10.1371/journal.pbio.0030374.g002
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Recruitment of Splicing Factorstau10þ14 transcripts, with more than 80% of cells showing an
accumulation in either cell type (Figure 4C). Similar to the
situation in tau10 1 cells, SF2/ASF was strongly recruited to
transcription sites in tau10þ3 and tau10þ14 cells, with more
than 80% of cells showing co-localization (Figure 4C), but was
only recruited to 31 6 2% of transcription sites in tau10wt
cells (Figure 4C). SC35 was recruited to 38 6 5% of tau10wt
transcription sites, but to more than 90% of transcription
sites in tau10þ3 or tau10þ14. We conclude that recruitment
of these proteins is determined by the splicing outcome and
not by the nature of the mutation near the splice site. Taken
together, these results suggest that SF2/ASF and SC35 are
differentially recruited to alternatively spliced transcripts
and that this recruitment correlates with splicing outcome.
Recruitment of Exogenous SR Proteins
The analysis of endogenous splicing factor recruitment is
restricted by the availability of only a limited set of speciﬁc
antibodies to SR proteins and simultaneous detection of
multiple splicing factors is prevented by species cross-
reactivity of the available antibodies. To expand our analysis
we introduced epitope-tagged SR proteins into tau-express-
ing cells using transient transfection. Since transient trans-
fection of SR proteins has previously been shown to be able
to affect alternative splicing outcome [19], we ﬁrst deter-
mined in a pilot experiment whether expression of SR
proteins alters alternative splice site choice in the stably
expressed tau minigene. Upon transfection of characterized
T7-tagged SRp20, SRp30s, SRp55, 9G8, or SF2/ASF [32,33], a
modest increase in inclusion was observed in tau10wt cells
and no effect was evident in tau10 1 cells (Figure 5A). The
absence of an effect was not due to sub-optimal transfection
efﬁciency since a majority of cells expressed the T7-tagged SR
Figure 3. Recruitment of Endogenous Pre-RNA Splicing Factors to
Transcription Sites Containing tau Exon 10 mRNA
(A) Recruitment of splicing factors to tau transcription sites detected by
combined RNA-FISH using a specific probe against tau exon 10 (green)
and IF microscopy with specific anti-splicing factor antibodies (red). All
associations were confirmed by linescan analysis. Scale bar ¼ 2.5 lm.
(B) Quantitation of percentage of cells with colocalization of tau RNA-
FISH and splicing factor signals. Values represent averages from at least
100 transcription sites from at least three experiments 6 SEM.
Recruitment to the subpopulation of transcription sites containing
predominantly tau exon10 mRNA in tau10wt cells was as efficient as
recruitment in tau10 1 cells.
DOI: 10.1371/journal.pbio.0030374.g003
Figure 4. Mutation-Independent Differential Recruitment of Endogenous
Pre-RNA Splicing Factors
(A) Stable cell lines expressing minigenes containing a G.A mutation at
þ3 (tau10þ3) or a C.U mutation atþ14 (tau10þ14). Both mutations give
preferential inclusion of exon 10 as previously reported for transient
expression.
(B) Quantitative real-time PCR analysis demonstrating the preferential
inclusion of exon 10 in tau10þ3 and tau10þ14 compared to tau10wt.
Values represent averages 6 standard deviations from at least three
experiments. Values of included exon 10 are normalized to total
minigene RNA.
(C) Quantitative analysis of recruitment of endogenous splicing factors to
tau10þ3 or tau10þ14. Recruitment of splicing factors to tau transcription
sites detected by combined RNA-FISH using specific probes against the
tau minigene and IF microscopy with specific anti-splicing factor
antibodies. Percentage of cells with colocalization of tau RNA-FISH and
splicing factor signals is indicated. Values represent averages from at
least 100 transcription sites from three experiments 6 SEM.
DOI: 10.1371/journal.pbio.0030374.g004
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Recruitment of Splicing Factorsproteins as conﬁrmed by ﬂuorescence microscopy staining
(unpublished data). When analyzed in the recruitment assay,
as a control and as observed for endogenous SF2/ASF,
transiently transfected T7-SF2/ASF was preferentially re-
cruited to tau10 1 (77 6 5%) compared to tau10wt tran-
scripts (54 6 9%; Figure 4B), further conﬁrming the
transient expression approach. The percentage of recruit-
ment-positive tau10wt cells appeared somewhat higher upon
transient transfection compared to that observed for the
endogenous protein (54 6 9% for transient; 31 6 2% for
endogenous), most likely due to the generally more diffuse
distribution of the overexpressed splicing factor [32].
Exogenous SRp20 behaved similarly to SF2/ASF and was
differentially recruited in tau10 1 cells compared to tau10wt
cells (Figure 5B). While T7-SRp20 was recruited in 56 6 9%
of tau10wt cells, the protein was found at tau-1 transcription
sites in 81 6 4% of cells (p , 0.005). No statistically
signiﬁcant differences were observed for the recruitment of
9G8, SRp30s and SRp55 with all proteins being recruited to
more than 70% in either tau10wt or tau10 1 cells (Figure 5B).
These observations suggest that SRp20 is similarly differ-
entially recruited to alternatively spliced tau as SF2/ASF.
Mapping of Differential Recruitment Domains in SF2/ASF
Our results on endogenous and exogenous SF2/ASF
demonstrate that this protein is preferentially recruited to
the tau minigene when exon 10 is included. We sought to
determine what parts of SF2/ASF were responsible for
recruitment to tau10 1. SF2/ASF contains two RNA-binding
domains in its N-terminal half and a characteristic SR-rich
protein–protein interaction domain at its C-terminus (Figure
6A). To ask whether recruitment involved RNA and/or
protein–protein interactions, we expressed a set of previously
characterized domain deletion mutations of SF2/ASF in
tau10 1 cells [32] (Figure 6A). As observed for the wt SF2/
ASF protein, expression of the deletion mutants had no
signiﬁcant effect on splicing outcome of tau10 1 (Figure 6B).
When the ability of these proteins to be recruited to tau10 1
was assessed, we found that deletion of any one domain
resulted in reduction of recruitment from 48 6 10% for the
wt control to ; 30–40% for any of the deletion mutants,
suggesting that no single domain alone is responsible for
recruitment (Figure 6C and 6 D). In contrast, deletion of any
combination of two domains resulted in almost complete loss
of recruitment (Figure 6C and 6D). None of these latter
mutants were recruited to transcription sites in more than
15% of cells (Figure 6C and 6D). Note that expression of the
RS-domain alone results in cell toxicity and was not analyzed
[32]. These observations suggest that all domains contribute
to recruitment of SF2/ASF to tau10 1 and that both RNA
binding as well as protein–protein interactions are required
for efﬁcient recruitment to alternatively spliced tau. The
involvement of multiple domains in the efﬁcient recruitment
to alternatively spliced transcripts is similar to the require-
ments for recruitment to constitutively spliced transcripts
[27].
Discussion
We have used quantitative single cell analysis to address the
long-standing question of whether differentially spliced
transcripts recruit distinct sets of basal pre-mRNA splicing
factors. Biochemical methods have been unable to resolve this
issue most likely due to the heterogeneity of isolated
transcripts and spliceosomes and the dynamic nature of the
spliceosome [2]. To circumvent these limitations, we have
applied a validated microscopy recruitment assay allowing us
to quantitatively analyze the association of splicing factors
with alternatively spliced transcripts in vivo. Based on
analysis of endogenous and exogenous SR proteins, we ﬁnd
that the accumulation of a subset of SR proteins at
transcription sites correlates with the inclusion of a alter-
natively spliced exon. While all tested SR proteins accumu-
lated at the transcription sites in cells where exon 10 of the
tau gene is predominantly included, several SR proteins,
including SF2/ASF, SC35, and SRp20, were found with
reduced frequency at transcription sites in cells where tau
exon 10 is excluded. The differentiation recruitment of a
subset of splicing factors gives rise to combinatorial
occupancy on the pre-mRNA.
Two general models for control of alternative splicing have
been suggested. A ﬁrst model envisions that alternative
splicing events are controlled by speciﬁc alternative splicing
factors. Clear examples of this model include sex-lethal in
Drosophila melanogaster and NOVA-1, a human neuron speciﬁc
alternative splicing factor [14,15]. However, use of dedicated
alternative splicing regulators might be the exception to the
Figure 5. Differential Recruitment of Exogenous Pre-RNA Splicing
Factors to tau Minigenes
(A) Semi-quantitative RT-PCR analysis of tau alternative splicing upon
expression of T7-tagged SR proteins in COS-7 cells expressing either
tau10wt or tau10 1. Transient transfection of splicing factors does not
affect the alternative splicing pattern of the tau minigene in stable cell
lines.
(B) Quantitative analysis of recruitment of transfected SR proteins to
tau10wt or tau10 1. Recruitment of splicing factors to tau transcription
sites detected by combined RNA-FISH using specific probes against the
tau minigene and IF microscopy with anti-T7 antibody. Percentage of
cells with colocalization of tau RNA-FISH and splicing factor signals is
indicated. Values represent averages from at least 100 transcription sites
from three experiments 6 SEM.
DOI: 10.1371/journal.pbio.0030374.g005
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Recruitment of Splicing Factorsrule. Considering that the majority of the approximately
25,000 human genes are alternatively spliced, many of them at
multiple sites, it is hard to image the existence of speciﬁc
splicing factors for all of these events. An alternative model
suggests that the outcome of alternative splicing is largely
determined by the combinatorial association of a commonly
used set of splicing factors [8]. Evidence for this model is the
fact that both in vivo and in vitro alternative splice site
selection can be inﬂuenced by antagonistic titration of
several splicing components [18–21]. In addition, this model
is in line with the observation that several antagonistic
splicing factors show tissue-speciﬁc abundance possibly
contributing to tissue speciﬁc splicing patterns [34]. Our
observations of differential recruitment of constitutive
splicing factors verify the key prediction of this model that
distinct sets of splicing factors associate with alternatively
spliced transcripts. Furthermore, as expected for this model,
recruitment of SF2/ASF involves the same protein regions as
recruitment to a constitutively spliced transcript suggesting
that recruitment to alternatively spliced introns is similar in
its molecular mechanisms as recruitment to constitutive
introns [27].
Given the differential recruitment of a subset of SR
proteins, these factors might be expected to contribute to
determining the splicing fate of tau exon 10. These proteins
have indeed been shown to slightly favor inclusion of exon 10
in transient transfections in COS-7 cells [31]. However, in our
hands only a moderate increase in exon 10 inclusion in the
stably integrated tau minigenes was detected upon over-
expression of SF2/ASF or SRp20. The limited ability of these
differentially recruited proteins to shift the splicing outcome
suggests that their mere presence at the template is not
sufﬁcient to control alternative splice site selection and that
they are not the sole determinants of splice site choice, but
that they cooperate with other spliceosome components. In
the absence of information on the stoichiometry of SR
proteins in spliceosomes involved in alternative splice site
choice, it is difﬁcult to predict the effect of their over-
expression on a given template.
Our ﬁndings are in line with a dynamic, largely stochastic
model for formation of the spliceosome on nascent RNA [8].
It seems likely that pre-mRNA splicing factors, which are
known to roam the nucleus by diffusion [35,36], are
temporarily captured near nascent pre-mRNAs by interac-
tion with the C-terminal domain of the largest subunit of
RNA polymerase [37,38]. Our observation of differential
accumulation of SR proteins suggests that their putative
interactions with the CTD are only transient, since stable
interaction would result in equal recruitment of SR proteins
to sites of transcription irrespective of splicing outcome.
Since binding events are dynamic and probabilistic, not all
assembled spliceosomes are identical and multiple types of
spliceosomes containing different combinations of sets of
splicing factors are formed. The nature of the formed
spliceosomes is likely determined by the cellular and local
abundance of factors, their post-translational modiﬁcations,
Figure 6. Deletion Mapping of Sf2/Asf Protein Domains Involved in
Differential Recruitment
(A) Schematic representation of T7-tagged mutants of SF2/ASF.
(B) Semi-quantitative RT-PCR analysis of tau10 1 splicing upon
expression of mutant SF2/ASF. Overexpression of the mutant proteins
does not affect tau splicing.
(C) Recruitment of splicing factors to tau transcription sites detected by
combined RNA-FISH using specific probes against the tau minigene
(green) and IF microscopy with anti-T7 antibody (red). Arrowheads
indicate tau transcription sites. Scale bar ¼ 2.5 lm.
(D) Quantitation of percentage of cells with colocalization of tau RNA-
FISH and splicing factor signals. Values represent averages from at least
50 transcription sites from three experiments 6 SEM.
DOI: 10.1371/journal.pbio.0030374.g006
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enhancers and repressor elements in the pre-mRNA. The
various types of spliceosomes likely have distinct functional
properties and recognize competing splice sites with differ-
ent efﬁciencies, thus generating a mixed population of
spliced transcripts. This model implies that alternative splice
site choice is not absolute and that multiple isoforms of
alternatively spliced transcripts should be generated for most
transcripts. This is indeed frequently observed for many
alternatively spliced pre-mRNAs, including endogenous tau
[29,39–41]. A striking example of the stochastic, combinato-
rial nature of alternative splicing is the presence of different
sets of isoforms of the axon guidance protein Dscam in D.
melanogaster, where individual neurons express distinct rep-
ertoires of Dscam isoform combinations providing a poten-
tial mechanism to establish cell identity [42].
A role for combinatorial dynamics in the assembly of the
spliceosome is fully consistent with the well-established
dynamic changes the spliceosome undergoes during the
splicing process where components are exchanged as the
splicing reaction progresses [2]. The advantage of a combi-
natorial mechanism for spliceosome formation is that it
offers the opportunity for cells to adjust splicing outcome
rapidly in response to intracellular or extracellular signals
without the need to synthesize a speciﬁc alternative splicing
factor, but merely by modulating the binding of the existing
splicing machinery by post-translational modiﬁcations or
change in cellular distribution. This provides an efﬁcient
regulatory link that allows rapid response to physiological
cues. Precedents for rapid, signal-mediated control of
alternative splicing by these mechanisms exist. Signaling-
mediated modulation of alternative splicing has been
demonstrated for CD44 via phosphorylation of splicing
factor Sam68 through the ERK pathway [43]. Similarly,
splicing of an adenoviral E1A splicing reporter is affected
by alterations of subcellular localization of hnRNPA1 con-
trolled through the MKK(3/6)-p38 pathway [44]. Based on the
sum of these considerations, we suggest that combinatorial
recruitment of constitutive splicing factors is an essential
property of spliceosomes that signiﬁcantly contributes to
generating protein diversity by alternative splicing and plays
a critical role in regulation of splicing in vivo.
Materials and Methods
Generation of stable tau cell lines. To generate a plasmid suitable
for generation of stable cell lines containing tau minigenes, the
characterized tau10wt,  1, þ3, and þ14 sequences were modiﬁed by
insertion of a zeocin selection cassette [30]. The tau minigene
constructs in pSPL3b were ﬁrst cut to completion with SphI and heat-
deactivated. The entire digest was then end-ﬁlled using Klenow
fragment and heat deactivated. The DNA was digested with AvrII to
completion and the plasmid gel puriﬁed. The zeocin cassette was
removed from pSV40 (Invitrogen, Carlsbad, California, United States)
via double digest with NheI and PvuII and was ligated into the tau
minigene plasmid in a 6:1 insert to vector ratio using T4 DNA ligase
overnight at 16 8C. This yielded pSPLZtau10.
To generate stable cell lines COS-1 cells were grown on a 100-mm
petri dish to 80% conﬂuence in Dulbecco’s modiﬁed essential
medium (DMEM), 10% FBS, 0.3 mg/ml L-glutamine, and 0.1 mg/ml
penicillin/streptomycin. Cells were trypsinized, resuspended in 10 ml
of DMEM, and pelleted at low speed. The supernatant was removed
and cells were resuspended in 200 ll of DMEM containing 4 lgo f
linearized pSPLZtau10 plasmid, and 16 lg of salmon sperm DNA in a
total volume of 30 ll. Cells were electroporated (2-mm gap cuvette,
four pulses at 1-ms pulse, and 150-V) in a BTX electroporator ECM
830 (BTX, Holliston, Massachusetts, United States). Cells were placed
on a 150-mm petri dish in DMEM overnight. For selection, cells were
incubated in DMEM containing 0.9 mg/ml zeocin (Invitrogen). After
1–2 wk, single colonies were selected and expanded in DMEM
containing 0.6 lg/ml zeocin. Clones were screened for expression of
the tau minigene by RT-PCR using primers located in the HIV-TAT
exons. Secondary screening was conducted by RNA-FISH. Stable lines
were routinely grown in DMEM with 0.4 lg/ml zeocin.
RT-PCR. Total RNA was extracted using either the RNAWhiz
reagent (Ambion, Austin, Texas, United States) or the RNAqueous kit
(Ambion) according to the manufacturer’s instructions. Conventional
RT-PCR was carried out as described in [45] except that Amplitaq
Gold (Applied Biosystems, Foster City, California, United States). was
used and the PCR reaction was initiated with a 109 hot start at 95 8C.
Quantitative real-time PCR, was performed using iQ SYBR Green
Supermix (Biorad, Hercules, California, United States) following the
manufacturer’s instructions and products ampliﬁed, detected, and
quantitated using a MyiQ (Biorad) single-color real-time PCR
detection system on an iCycler (BioRad). The PCR routine consisted
of 3 min at 94 8C, followed by 60 cycles of 20 s at 95 8C, and 1 min at
58 8C. For detection of tau mRNA containing exon 10, the following
primers (forward, 59-TGC AGA TAA TTA ATA AGA AGC TGG AT-
39; and reverse, 5,9- CCG GGA CGT GTT TGA TAT T-39) located
within exon 10 were used. This reaction yields an 81-nucleotide
product. To measure the total amount of tau minigene mRNA, the
following primers (forward, 59-GTC ACC TGG ACA ACC TCA AA-39;
and reverse, 59-CAG CTT GTC ACA GTG CAG TT-39) located in the
TAT donor exon upstream of exon 10 were used. This reaction yields
a 62-nucleotide product. Ampliﬁcation efﬁciencies were above 90%
and production of single bands was conﬁrmed by gel electrophoresis
and melting curve analysis in the same run as measurements were
done. RNA amounts were determined using calibrated standard
curves using a dilution series over ﬁve orders of magnitude. Amounts
of exon 10-containing mRNA were normalized to total tau minigene
RNA. Values represent averages from at least two experiments 6
standard deviations.
To determine the effect of overexpression of SR proteins on tau
minigene splicing, COS-1 cells stably expressing tau10wt or tau10 1
were transiently transfected as described above with T7-tagged SR
protein expression constructs in pCG-T7 as described in [32].
Microscopy was performed 16 h post-transfection.
FISH and IF microscopy. Stable cell lines were treated for FISH
exactly as described in [27] except that 0.1% Triton was used during
the initial ﬁxation instead of 0.5%. IF was performed exactly as
described in [46]. For detection of endogenous splicing factors, FISH
was carried out prior to IF without ﬁxation or permeabilization steps
between the two procedures. Cells transiently transfected with T7-
tagged splicing factors were ﬁrst subjected to IF, postﬁxed in 2%
paraformaldehyde for 10 min followed by three rinses in PBS of 5
min each. RNA-FISH was then performed overnight. Tau was
detected using probes against the entire minigene or a probe
spanning the entire exon 10 generated by nick-translation as
previously described [27].
Microscopy and quantitative recruitment assay. Images were
collected on a Leica TCS-SP confocal microscope. Single optical
sections using 83 averaging were acquired by simultaneous scanning
to avoid artifactual shift between the two optical channels. The 488-
nm laser line of an Ar laser was used for detection of FITC RNA-FISH
signals and the 568-nm line of a Kr laser for detection of TexasRed IF
signals. Images were analyzed using Metamorph imaging software
(Universal Imaging, Downington, Pennsylvania, United States).
Recruitment was detected as accumulation of the IF signal at the
tau site of transcription as previously described [27]. Positive
recruitment was deﬁned by two simultaneous criteria: a) the splicing
factor signal was accumulated at the transcription site more than 2-
fold above nucleoplasmic signal and b) at least half the splicing factor
intensity peak overlapped with at least half of the RNA-FISH
intensity peak. All quantitations were performed on unprocessed 8-
bit grayscale images with no saturated pixels. At least 100 foci from at
least three experiments were quantitated for each splicing factor per
cell line. Statistical analysis was performed using a standard Student
t-test.
For SF2/ASF mutants that do not give a distinct speckled pattern,
quantitation was performed by measuring the average pixel intensity
of the TexasRed signal at the transcription site and comparing it to
the average TexasRed signal in the rest of the nucleus excluding
nucleoli. Enrichment of the splicing factor signal of . 1.4-fold above
its average nuclear intensity was deﬁned as recruitment. This
threshold was determined empirically by comparing the degree of
recruitment of T-7 tagged SF2/ASF using the two quantitation
PLoS Biology | www.plosbiology.org November 2005 | Volume 3 | Issue 11 | e374 1900
Recruitment of Splicing Factorsmethods. At least 50 foci from at least three experiments were
analyzed for each SF2/ASF mutant.
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